Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstroRx® shows promise in early phase amyotrophic lateral sclerosis trial

europeanpharmaceuticalreviewDecember 17, 2020

Tag: AstroRx , ALS , Kadimastem , Clinical Trial

PharmaSources Customer Service